Becro (Cyprus) Limited
- Address
- Chanteclair Building 1st Floor, Office 108, Sofouli 16
Sponsor Overview
Specializations
Ophthalmology and Glaucoma
Clinical research activity is centered on open-angle glaucoma, with interest in disease control linked to intraocular pressure and the preservation of optic nerve function. The sponsor also engages in studies relevant to ocular hypertension, a related condition in which elevated eye pressure is a key clinical concern.
- Open-angle glaucoma
- Ocular hypertension
- Intraocular pressure management
Its research footprint in this area reflects a focus on therapies used in chronic eye disease and visual field preservation.
Fixed-combination Topical Eye Therapies
The sponsor has interest in ophthalmic combination treatments, particularly formulations pairing brimonidine and timolol for pressure-lowering treatment in glaucoma care. Research activity includes evaluation of preservative-containing and preservative-free eye drop presentations used in long-term management.
- Brimonidine/timolol combinations
- Topical ophthalmic solutions
- Single-dose container formulations
This area highlights therapeutic interest in practical eye-drop delivery options for chronic glaucoma treatment.
Vision Preservation and Pressure-lowering Treatment
Research priorities extend to therapies aimed at reducing intraocular pressure to limit progression toward visual impairment and blindness. The sponsor’s clinical activity is aligned with treatment approaches intended to support ongoing control of chronic anterior segment disease.
- Visual field protection
- Optic disc changes
- Chronic pressure-lowering therapy
The therapeutic emphasis remains on maintaining ocular function in patients requiring sustained treatment.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Non-Inferiority Trial of Brimonidine Tartrate/Timolol Maleate Eye Drops Versus Combigan in Open-Angle Glaucoma or Ocular Hypertension Patients |  Greece | Not Recruiting |
Data & Insights
This sponsor works with 2 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 12 sites across their trial portfolio.
Therapeutic Focus
- 1.Eye Diseases1 trial138 other sponsors
Partnered Research Centres
12 centres- Address
- Terminal of Tavropos, 43100 Karditsa
- Address
- Tsakalof 1, 412 21 Larissa
- Address
- Kalavriton 37, 265 00 Pátrai
- Address
- Karditsis 56, 421 31 Trikala
- Address
- 8th Km Old National Road Larissa-Athens, 410 00 Larissa
- Address
- Konstadinoupoleos 49, 546 42 Thessaloniki
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Becro (Cyprus) Limited.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.